Annual Total Long Term Liabilities
$333.14 M
+$332.56 M+56556.97%
December 31, 2024
Summary
- As of March 13, 2025, SNDX annual total long term liabilities is $333.14 million, with the most recent change of +$332.56 million (+56556.97%) on December 31, 2024.
- During the last 3 years, SNDX annual total long term liabilities has risen by +$312.54 million (+1516.73%).
- SNDX annual total long term liabilities is now at all-time high.
Performance
SNDX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$333.14 M
+$333.14 M+16657050.00%
December 31, 2024
Summary
- As of March 13, 2025, SNDX quarterly total long term liabilities is $333.14 million, with the most recent change of +$333.14 million (+16657050.00%) on December 31, 2024.
- Over the past year, SNDX quarterly long term liabilities has increased by +$333.14 million (+16657050.00%).
- SNDX quarterly long term liabilities is now at all-time high.
Performance
SNDX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SNDX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +10000.0% |
| 3 y3 years | +1516.7% | +10000.0% |
| 5 y5 years | +2357.3% | +10000.0% |
SNDX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Syndax Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $333.14 M(>+9900.0%) | $333.14 M(>+9900.0%) |
| Sep 2024 | - | $2000.00(-98.5%) |
| Jun 2024 | - | $137.00 K(-59.0%) |
| Mar 2024 | - | $334.00 K(-43.2%) |
| Dec 2023 | $588.00 K(-18.6%) | $588.00 K(-31.9%) |
| Sep 2023 | - | $864.00 K(-23.6%) |
| Jun 2023 | - | $1.13 M(+88.5%) |
| Mar 2023 | - | $600.00 K(-16.9%) |
| Dec 2022 | $722.00 K(-96.5%) | $722.00 K(-7.7%) |
| Sep 2022 | - | $782.00 K(-94.2%) |
| Jun 2022 | - | $13.57 M(-20.7%) |
| Mar 2022 | - | $17.12 M(-16.9%) |
| Dec 2021 | $20.61 M(-30.3%) | $20.61 M(+74.8%) |
| Sep 2021 | - | $11.79 M(-51.3%) |
| Jun 2021 | - | $24.20 M(-10.0%) |
| Mar 2021 | - | $26.90 M(-9.0%) |
| Dec 2020 | $29.55 M(+118.0%) | $29.55 M(-8.1%) |
| Sep 2020 | - | $32.17 M(-1.0%) |
| Jun 2020 | - | $32.51 M(-1.0%) |
| Mar 2020 | - | $32.86 M(+142.4%) |
| Dec 2019 | $13.56 M | $13.56 M(-3.5%) |
| Sep 2019 | - | $14.04 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $14.62 M(-3.2%) |
| Mar 2019 | - | $15.11 M(+2.2%) |
| Dec 2018 | $14.79 M(-13.4%) | $14.79 M(-2.6%) |
| Sep 2018 | - | $15.18 M(-3.5%) |
| Jun 2018 | - | $15.72 M(-2.4%) |
| Mar 2018 | - | $16.10 M(-5.7%) |
| Dec 2017 | $17.07 M(+17.7%) | $17.07 M(+25.8%) |
| Sep 2017 | - | $13.57 M(-1.8%) |
| Jun 2017 | - | $13.82 M(-1.7%) |
| Mar 2017 | - | $14.06 M(-3.1%) |
| Dec 2016 | $14.51 M(-21.0%) | $14.51 M(-1.6%) |
| Sep 2016 | - | $14.75 M(-2.1%) |
| Jun 2016 | - | $15.06 M(-2.1%) |
| Mar 2016 | - | $15.38 M(-16.2%) |
| Dec 2015 | $18.36 M(+124.3%) | $18.36 M(-1.3%) |
| Sep 2015 | - | $18.61 M(+127.3%) |
| Dec 2014 | $8.19 M(+229.8%) | $8.19 M(+56.1%) |
| Sep 2014 | - | $5.24 M(+620.2%) |
| Jun 2014 | - | $728.00 K(-71.6%) |
| Mar 2014 | - | $2.57 M(+3.4%) |
| Dec 2013 | $2.48 M(-56.4%) | $2.48 M |
| Dec 2012 | $5.69 M | - |
FAQ
- What is Syndax Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Syndax Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Syndax Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of SNDX is $333.14 M
What is the all time high annual total long term liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual total long term liabilities is $333.14 M
What is Syndax Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, SNDX annual total long term liabilities has changed by +$332.56 M (+56556.97%)
What is Syndax Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of SNDX is $333.14 M
What is the all time high quarterly long term liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly total long term liabilities is $333.14 M
What is Syndax Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, SNDX quarterly total long term liabilities has changed by +$333.14 M (+16657050.00%)